© Reuters. FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid
(Reuters) -Johnson & Johnson said on Tuesday it would suspend the supply of its personal care products in Russia, adding it would continue to supply medicines and medical devices in the region.
The company, along with several other drugmakers such as Eli Lilly (NYSE:) and Co and Pfizer (NYSE:), said earlier this month it would stop enrollment in clinical trials in Russia.
J&J (NYSE:) had said it was stopping enrollment in Ukraine and Belarus as well as new site openings, but was committed to providing essential health products.
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.